3.23
Cronos Group Inc stock is traded at $3.23, with a volume of 411.14K.
It is up +0.31% in the last 24 hours and up +2.38% over the past month.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
See More
Previous Close:
$3.22
Open:
$3.23
24h Volume:
411.14K
Relative Volume:
0.41
Market Cap:
$1.19B
Revenue:
$159.54M
Net Income/Loss:
$5.06M
P/E Ratio:
-734.09
EPS:
-0.0044
Net Cash Flow:
$26.19M
1W Performance:
+0.16%
1M Performance:
+2.38%
6M Performance:
+26.67%
1Y Performance:
+19.19%
Cronos Group Inc Stock (CRON) Company Profile
Name
Cronos Group Inc
Sector
Phone
(416) 504-0004
Address
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CRON
Cronos Group Inc
|
3.23 | 1.19B | 159.54M | 5.06M | 26.19M | -0.0044 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.73 | 59.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.10 | 47.93B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.32 | 40.99B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
74.81 | 30.91B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
549.16 | 23.55B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-28-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-11-22 | Upgrade | CIBC | Neutral → Sector Outperform |
| Mar-22-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-27-22 | Upgrade | Jefferies | Underperform → Hold |
| Nov-18-21 | Resumed | BofA Securities | Underperform |
| Apr-28-21 | Resumed | BofA Securities | Underperform |
| Feb-22-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-24-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-27-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-14-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-02-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-31-20 | Downgrade | Canaccord Genuity | Hold → Sell |
| Mar-04-20 | Upgrade | MKM Partners | Neutral → Buy |
| Mar-03-20 | Downgrade | Stifel | Buy → Hold |
| Oct-18-19 | Upgrade | Stifel | Hold → Buy |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-05-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Aug-13-19 | Initiated | Piper Jaffray | Overweight |
| Aug-09-19 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-28-19 | Initiated | Consumer Edge Research | Equal Weight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Upgrade | BofA/Merrill | Underperform → Buy |
| Apr-17-19 | Initiated | BofA/Merrill | Underperform |
| Mar-27-19 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-25-19 | Initiated | Jefferies | Underperform |
| Jan-18-19 | Initiated | CIBC | Sector Outperform |
View All
Cronos Group Inc Stock (CRON) Latest News
CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out? - Zacks Investment Research
Cronos Group (NASDAQ:CRON) Rides Record Quarters and Israel Momentum - Kalkine Media
What Does the Dutch Deal Deadline Extension Mean for Cronos Group (NASDAQ:CRON)? - Kalkine Media
Why is Cronos Group (NASDAQ:CRON) stock jumping on cannabis rescheduling buzz? - Kalkine Media
What's Behind Cronos Group's (NASDAQ:CRON) Big Moment in Cannabis Stocks Today? - Kalkine Media
Cronos Group (NASDAQ:CRON) Extends Dutch Acquisition Deadline as Cannabis Reform Talk Revives - Kalkine Media
Is Cronos Group (NASDAQ:CRON) the Cannabis Stocks Stock Everyone's Talking About? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) Suddenly a Must-Watch Cannabis Stocks Stock Today? - Kalkine Media
What Did Cronos Group (NASDAQ:CRON) Share at Its First Strategy Day? - Kalkine Media
Cronos Group $10 Million Securities Class Action Settlement - Claim Depot
Can Cronos Group (NASDAQ:CRON) Sustain Its Record Revenue Streak? - Kalkine Media
Labaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities Settlement - Yahoo! Finance Canada
Labaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities Settlement - ca.finance.yahoo.com
Why is Cronos Group (NASDAQ:CRON) in focus amid today’s cannabis stocks discussion? - Kalkine Media
Is Cronos Group (NASDAQ:CRON) Stock Worth Watching Today? - Kalkine Media
2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026 - The Motley Fool
Cronos Group’s CAD 1.13 Billion Liquidity Position Strengthens Financial Flexibility as Global Cannabis Expansion Accelerates - kalkine.ca
Cronos Group Inc. (NASDAQ:CRON) Given Average Rating of "Hold" by Brokerages - MarketBeat
Cronos Group Extends Long Stop Date To October 15 For Canadelaar BV DealSEC Filing - TradingView
Cronos Group Inc. (TSX:CRON) Advances as Cannabis Brand Growth and International Expansion Strengthen Investor Outlook - kalkine.ca
Why is Cronos Group (NASDAQ:CRON) stock in focus today? - Kalkine Media
Cronos Group (NASDAQ:CRON): What's Moving During A Choppy Session? - Kalkine Media
Cronos Group (TSX:CRON) Gains Attention Amid Cannabis Sector Shifts - Kalkine Media
Can Cronos Group (TSX:CRON) Sustain Its Growth Momentum? - Kalkine Media
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
Could Cronos Group Inc. (TSX:CRON) Drive Cannabis Stock Interest? - Kalkine Media
Cronos Group Inc (TSX:CRON): Why Cannabis Market Trends Matter? - Kalkine Media
Cronos Group (NASDAQ:CRON): Steady Growth Behind A Quiet Cannabis Name - Kalkine Media
Why Are These Canadian Penny Stocks Turning Heads? - Kalkine Media
Cronos Group Inc (CRON): Why This Canadian-Listed Stock Could Be One to Watch in September - kalkine.ca
Cronos Group (TSX:CRON): What's Really Driving Recent Stock Momentum? - Kalkine Media
Does Cronos Group's (TSX:CRON) New Launch Signal Growth? - Kalkine Media
Is Cronos Group’s (TSX:CRON) Live Resin Push a Turning Point for Its Brand Strategy? - simplywall.st
Is Cronos Group’s (TSX:CRON) Live Resin Push a Turning Point for Its Brand Strategy? - simplywall.st
CRON News | CRONOS GROUP INC (NASDAQ:CRON) - ChartMill
Cronos Group (NASDAQ:CRON): Is Today’s Move A Sector Signal? - Kalkine Media
Arbutus Biopharma Corp (ABUS) Peer Comparison – Compare with Others - Value Research
Cronos Group Inc. Common Share (CRON) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Why Is Cronos Group (NASDAQ:CRON) Posting Record Quarter as Israel Growth and New Edibles Roll Out? - Kalkine Media
Cronos Group Inc. Common Share (CRON) Key Financial Ratios – Valuation, Profitability & More - Value Research
Cannabis Stocks Spotlight: Cronos Group (TSX:CRON) Explained - Kalkine Media
Cronos Group Stock Slides as Cannabis Volatility Raises Fresh Correction Risk - kalkine.ca
Cronos Group Inc. (TSX:CRON) Falls 4.49% as Cannabis Stock Faces Profit-Taking, Regulatory Risk and Renewed Downside Pressure - kalkine.ca
Why Is Nasdaq Watching Cronos Group (NASDAQ:CRON) This Week? - Kalkine Media
Cronos Group Inc. stock falls Wednesday, underperforms market - marketwatch.com
Is Cronos Group’s Dutch Strategy A Cannabis Catalyst? - Kalkine Media
Promising Cannabis Stocks To Watch NowSeptember 2nd - MarketBeat
Are Medical Stocks Lagging Cronos Group (CRON) This Year? - Yahoo Finance
Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes - GlobeNewswire
Why Cronos Group (NASDAQ:CRON) Just Extended Its CanAdelaar Deadline? - Kalkine Media
Cronos Group Inc Stock (CRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cronos Group Inc Stock (CRON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wagner Adam | See remarks |
May 12 '26 |
Option Exercise |
0.00 |
10,367 |
0 |
103,987 |
| Buggy Shannon | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
20,622 |
0 |
187,501 |
| Kenost Jared Matthew | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
9,412 |
0 |
46,675 |
| Weigensberg Arye | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
3,118 |
0 |
211,555 |
| Wagner Adam | See remarks |
May 10 '26 |
Option Exercise |
0.00 |
20,470 |
0 |
93,620 |
| Kenost Jared Matthew | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
12,649 |
0 |
39,141 |
| Shlimak Anna | See Remarks |
Mar 19 '26 |
Option Exercise |
0.00 |
28,429 |
0 |
368,362 |
| Doucet Terrence Gregory Joseph | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
23,897 |
0 |
117,466 |
| Weigensberg Arye | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
24,236 |
0 |
208,437 |
| GORENSTEIN MICHAEL RYAN | See remarks below |
Mar 15 '26 |
Option Exercise |
0.00 |
324,540 |
0 |
13,340,723 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):